OBJECTIVE: To study the impact of terminations of pregnancy (TOP) on very preterm mortality in Europe. DESIGN: European prospective population-based cohort study. SETTING: Ten regions from nine European countries participating in the MOSAIC (Models of OrganiSing Access to Intensive Care for very preterm babies) study. These regions had different policies on screening for congenital anomalies (CAs) and on pregnancy termination. POPULATION OR SAMPLE: Births 22-31 weeks gestational age. METHODS: The analysis compares the proportion of TOP among very preterm births and assesses differences in mortality between the regions. MAIN OUTCOME MEASURES: Pregnancy outcomes (termination, antepartum death, intrapartum death and live birth) and reasons for termination, presence of CAs and causes of death for stillbirths and live births in 2003. RESULTS: Pregnancy terminations constituted between 1 and 21.5% of all very preterm births and between 4 and 53% of stillbirths. Most terminations were for CAs, although some were for obstetric indications (severe pre-eclampsia, growth restriction, premature rupture of membranes). TOP contributed substantially to overall fetal mortality rates in the two regions with late second-trimester screening. There was no clear association between policies governing screening and pregnancy termination and the proportion of CAs among stillbirths and live births, except in Poland, where neonatal deaths associated with CAs were more frequent, reflecting restrictive pregnancy termination policies. CONCLUSION: Proportions of TOP among very preterm births varied widely between European regions. Information on terminations should be reported when very preterm live births and stillbirths are compared internationally since national policies related to screening for CAs and the legality and timing of medical terminations differ.
OBJECTIVE: To study the impact of terminations of pregnancy (TOP) on very preterm mortality in Europe. DESIGN: European prospective population-based cohort study. SETTING: Ten regions from nine European countries participating in the MOSAIC (Models of OrganiSing Access to Intensive Care for very preterm babies) study. These regions had different policies on screening for congenital anomalies (CAs) and on pregnancy termination. POPULATION OR SAMPLE: Births 22-31 weeks gestational age. METHODS: The analysis compares the proportion of TOP among very preterm births and assesses differences in mortality between the regions. MAIN OUTCOME MEASURES: Pregnancy outcomes (termination, antepartum death, intrapartum death and live birth) and reasons for termination, presence of CAs and causes of death for stillbirths and live births in 2003. RESULTS: Pregnancy terminations constituted between 1 and 21.5% of all very preterm births and between 4 and 53% of stillbirths. Most terminations were for CAs, although some were for obstetric indications (severe pre-eclampsia, growth restriction, premature rupture of membranes). TOP contributed substantially to overall fetal mortality rates in the two regions with late second-trimester screening. There was no clear association between policies governing screening and pregnancy termination and the proportion of CAs among stillbirths and live births, except in Poland, where neonatal deaths associated with CAs were more frequent, reflecting restrictive pregnancy termination policies. CONCLUSION: Proportions of TOP among very preterm births varied widely between European regions. Information on terminations should be reported when very preterm live births and stillbirths are compared internationally since national policies related to screening for CAs and the legality and timing of medical terminations differ.
Authors: Ashna D Mohangoo; Simone E Buitendijk; Katarzyna Szamotulska; Jim Chalmers; Lorentz M Irgens; Francisco Bolumar; Jan G Nijhuis; Jennifer Zeitlin Journal: PLoS One Date: 2011-11-16 Impact factor: 3.240
Authors: Jennifer Zeitlin; Laust Mortensen; Marina Cuttini; Nicholas Lack; Jan Nijhuis; Gerald Haidinger; Béatrice Blondel; Ashna D Hindori-Mohangoo Journal: J Epidemiol Community Health Date: 2015-12-30 Impact factor: 3.710
Authors: Anna Karin Edstedt Bonamy; Jennifer Zeitlin; Aurélie Piedvache; Rolf F Maier; Arno van Heijst; Heili Varendi; Bradley N Manktelow; Alan Fenton; Jan Mazela; Marina Cuttini; Mikael Norman; Stavros Petrou; Patrick Van Reempts; Henrique Barros; Elizabeth S Draper Journal: Arch Dis Child Fetal Neonatal Ed Date: 2018-01-20 Impact factor: 5.747
Authors: Jennifer Zeitlin; Rolf F Maier; Marina Cuttini; Ulrika Aden; Klaus Boerch; Janusz Gadzinowski; Pierre-Henri Jarreau; Jo Lebeer; Mikael Norman; Pernille Pedersen; Stavros Petrou; Johanna M Pfeil; Liis Toome; Arno van Heijst; Patrick Van Reempts; Heili Varendi; Henrique Barros; Elizabeth S Draper Journal: Int J Epidemiol Date: 2020-04-01 Impact factor: 7.196
Authors: M Delnord; A D Hindori-Mohangoo; L K Smith; K Szamotulska; J L Richards; P Deb-Rinker; J Rouleau; P Velebil; I Zile; L Sakkeus; M Gissler; N Morisaki; S M Dolan; M R Kramer; M S Kramer; J Zeitlin Journal: BJOG Date: 2016-09-10 Impact factor: 6.531
Authors: Paromita Deb-Rinker; Juan Andrés León; Nicolas L Gilbert; Jocelyn Rouleau; Anne-Marie Nybo Andersen; Ragnheiður I Bjarnadóttir; Mika Gissler; Laust H Mortensen; Rolv Skjærven; Stein Emil Vollset; Xun Zhang; Prakesh S Shah; Reg S Sauve; Michael S Kramer; K S Joseph Journal: BMC Pediatr Date: 2015-09-04 Impact factor: 2.125
Authors: Jennifer Zeitlin; Bradley N Manktelow; Aurelie Piedvache; Marina Cuttini; Elaine Boyle; Arno van Heijst; Janusz Gadzinowski; Patrick Van Reempts; Lene Huusom; Tom Weber; Stephan Schmidt; Henrique Barros; Dominico Dillalo; Liis Toome; Mikael Norman; Beatrice Blondel; Mercedes Bonet; Elisabeth S Draper; Rolf F Maier Journal: BMJ Date: 2016-07-05
Authors: Laure Dombrecht; Kim Beernaert; Ellen Roets; Kenneth Chambaere; Filip Cools; Linde Goossens; Gunnar Naulaers; Luc De Catte; Joachim Cohen; Luc Deliens Journal: BMC Pediatr Date: 2018-08-03 Impact factor: 2.125